Home > Creating new antiviral drugs: UMBC professor’s innovative “fleximer” research to receive $3.5M from NIH
Creating new antiviral drugs: UMBC professor’s innovative “fleximer” research to receive $3.5M from NIH
Due to their flexibility, Katherine Seley-Radtke’s fleximers can be more effective against multiple similar viruses or a virus that has accumulated some mutations.
Stay Connected
X (formerly Twitter)
Facebook
YouTube
LinkedIn
RSS